How can human biology data improve target selection? Learn how one discovery programme identified a potential new treatment ...

Introduction Stroke remains a leading cause of disability and mortality worldwide, with an urgent need for novel therapeutic strategies to improve recovery. Bupropion hydrochloride, a ...

Patients with no other options are watching an agency turn on its own scientists — and the trust that took a century to build ...

Final trial results add to evidence supporting use in tots who remain at increased risk ...

Biopharma companies must weigh the operational complexity of continuous bioprocess against its potential productivity gains.

D-150 gene therapy enters pivotal Wet-AMD/DME trials, cutting injections up to 89%. Click for this FDMT update.

The Department of Labor (DOL) has filed a brief in support of plan fiduciaries in a case before the Supreme Court in what was described as one of a “series filed by the Departme ...

The selective D1/D5 agonist significantly improved Parkinson’s disease motor symptoms, with low rates of somnolence and ...

A novel oral ketamine drug was well tolerated and associated with reduced depressive symptoms in treatment-resistant depression (TRD) without significant dissociative effects, findings from two ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

NDA submission and improved EBITDA Second quarter 2026Net sales for the quarter totaled MSEK 49.1 (49.8), equivalent to a decrease of 1% compared to the corresponding quarter in 2025. At constant exch ...